Recombinant Rat AOX3L1 Protein
Cat.No. : | AOX3L1-696R |
Product Overview : | Recombinant Rat AOX3L1 full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Rat |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC. |
Storage Buffer : | PBS buffer |
Gene Name : | Aox3l1 aldehyde oxidase 3-like 1 [ Rattus norvegicus ] |
Official Symbol : | AOX3L1 |
Gene ID : | 316421 |
mRNA Refseq : | NM_001008522.1 |
Protein Refseq : | NP_001008522.1 |
MIM : | |
UniProt ID : | Q5QE78 |
Products Types
◆ Recombinant Protein | ||
AOX3L1-593M | Recombinant Mouse AOX3L1 Protein, His (Fc)-Avi-tagged | +Inquiry |
AOX3L1-352R | Recombinant Rat AOX3L1 Protein, His (Fc)-Avi-tagged | +Inquiry |
AOX3L1-1727M | Recombinant Mouse AOX3L1 Protein | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (15)
Ask a questionThe current study shows that the AOX3L1 recombinant protein does not cause a significant immune response, but individual differences should not be ignored.
No clinical trials have been found on AOX3L1 , but may be conducted in the future.
AOX3L1 recombinant protein may have innovative and unique advantages over existing therapies, but more clinical trials are needed to confirm this.
AOX3L1 has potential clinical application, which may be used to treat certain diseases or as a biomarker.
The preparation method of AOX3L1 generally involves gene engineering technology, including gene cloning, expression and purification.
AOX3L1 recombinant protein may be used to treat neurodegenerative diseases, fetal abnormalities, and some inflammatory diseases. The X3L1 recombinant protein has obvious interaction with other drugs.
AOX3L1 may be involved in a variety of mechanisms, such as inhibiting inflammatory response, promoting cell repair and regulating immune function.
Yes, the AOX3L1 can be used in tissue engineering to help promote cell growth and regeneration.
There have been no studies demonstrating serious side effects of AOX3L1 , but care needs to be taken to monitor patient responses during clinical use.
The production process of AOX3L1 recombinant protein is currently being continuously improved and optimized to ensure the quality and stability of production.
The AOX3L1 can be combined with the drug carrier to enhance the drug delivery effect and improve the therapeutic effect.
AOX3L1 bioactivity can be evaluated by a series of in vitro and in vivo experiments, such as cell proliferation, enzyme activity and function tests.
The safety and efficacy of AOX3L1 in children needs more research and clinical data.
AOX3L1 may play a role in the treatment of a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
AOX3L1 may play a role in inhibiting tumor growth and promoting tumor cell apoptosis in tumor therapy.
Customer Reviews (4)
Write a reviewThe background in the Western blot was very clean and showed good antibody specificity.
In the long-term storage process, the stability of this protein is very good, after a long time of storage, its performance remains unchanged, indicating that it has excellent storage stability.
I get consistent results from each experiment gives me more confidence in the results.
It has a wide range of applications and can be used in various biological experiments.
Ask a Question for All AOX3L1 Products
Required fields are marked with *
My Review for All AOX3L1 Products
Required fields are marked with *
Inquiry Basket